Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Meningococcal Vaccines Market: By Type: Polysaccharide Vaccine, Conjugate Vaccine, Serogroup B Vaccine; By Age Group: Infants, Children, Adults, Others; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Meningococcal Vaccines Market Outlook
The global meningococcal vaccines market stood at 172 million doses in 2020. The global meningococcal vaccines market is expected to grow at a healthy pace in the forecast period of 2023-2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Prevalence of Meningococcal Meningitis to Aid the Market Growth of Meningococcal Vaccines
The market growth of meningococcal vaccines is being driven by the rising prevalence of various types of bacteria that trigger meningococcal meningitis. The most common among them are A, B, C, W, Y, and type X that was lately tracked in Africa. This is aiding the market growth of meningococcal vaccines as the demand for effective meningococcal vaccines is on the rise over the forecast period. The market is further being propelled by the extremely unpredictable dissemination of this bacteria and fluctuating occurrences of the disease over time and across different age groups and geographies, which has resulted in a considerable increase in the frequency of clinical programmes for the development of efficient meningococcal vaccines worldwide. Moreover, several ongoing clinical programmes for the development of meningococcal vaccines at varying stages is further facilitating the market growth globally.
Meningococcal Vaccines: Market Segmentation
Meningococcal meningitis is a rare and potentially disturbing bacterial infection that affects the brain. Even after the advances in the medical field, the disease has the potential to take the life of the host in a relatively lesser timespan. Meningococcal vaccines are produced as the prevention of meningococcal meningitis.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of type, the market is divided into:
- Polysaccharide Vaccine (MPSV4)
- Conjugate Vaccine (MCV4)
- Serogroup B Vaccine (MenB-FHpb/MenB-4C)
Based on age group, the industry can be segmented into:
- Infants
- Children
- Adults
- Others
By distribution channel, the industry is categorised into:
- Institutional Sales
- Retail Sales
These segments are further divided on the basis of type. Institutional sales are divided into hospitals, community clinics, and public health agencies, whereas retail sales are divided into retail pharmacy and online, among others.
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Initiatives by the Government to Aid the Market Growth of Meningococcal Vaccines
The market growth of meningococcal vaccines is being driven by the rising initiatives like National Immunization Programs (NIPs) by the governments and supported by private non-profit organisations for the development of meningococcal vaccines. Further, the addition of meningococcal vaccines to NIPs with the motive to ascertain vaccine supply affordability and sustainability in public and private sectors has been generating an abundance of opportunities for the manufacturers.
Key Industry Players in the Global Meningococcal Vaccines Market
The report gives a detailed analysis of the following key players in the global meningococcal vaccines market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Pfizer Inc.
- Sanofi SA
- GlaxoSmithKline plc
- Incepta Vaccine Ltd.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Age Group, Distribution Channel, Region |
| Breakup by Type | Polysaccharide Vaccine (MPSV4), Conjugate Vaccine (MCV4), Serogroup B Vaccine (MenB-FHpb/MenB-4C) |
| Breakup by Age Group | Infants, Children, Adults, Others |
| Breakup by Distribution Channel | Institutional Sales, Retail Sales |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Pfizer Inc., Sanofi SA, GlaxoSmithKline plc, Incepta Vaccine Ltd., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Meningococcal Vaccines Market Analysis
8.1 Key Industry Highlights
8.2 Global Meningococcal Vaccines Historical Market (2018-2022)
8.3 Global Meningococcal Vaccines Market Forecast (2023-2028)
8.4 Global Meningococcal Vaccines Market by Type
8.4.1 Polysaccharide Vaccine (MPSV4)
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Conjugate Vaccine (MCV4)
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Serogroup B Vaccine (MenB-FHpb/MenB-4C)
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.5 Global Meningococcal Vaccines Market by Age Group
8.5.1 Infants
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Children
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Adults
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Others
8.6 Global Meningococcal Vaccines Market by Distribution Channel
8.6.1 Institutional Sales
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.1.4 Breakup by Type
8.6.1.4.1 Hospitals
8.6.1.4.1.1 Market Share
8.6.1.4.1.2 Historical Trend (2018-2022)
8.6.1.4.1.3 Forecast Trend (2023-2028)
8.6.1.4.2 Community Clinics
8.6.1.4.2.1 Market Share
8.6.1.4.2.2 Historical Trend (2018-2022)
8.6.1.4.2.3 Forecast Trend (2023-2028)
8.6.1.4.3 Public Health Agencies
8.6.1.4.3.1 Market Share
8.6.1.4.3.2 Historical Trend (2018-2022)
8.6.1.4.3.3 Forecast Trend (2023-2028)
8.6.2 Retail Sales
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.2.4 Breakup by Type
8.6.2.4.1 Retail Pharmacy
8.6.2.4.1.1 Market Share
8.6.2.4.1.2 Historical Trend (2018-2022)
8.6.2.4.1.3 Forecast Trend (2023-2028)
8.6.2.4.2 Online
8.6.2.4.2.1 Market Share
8.6.2.4.2.2 Historical Trend (2018-2022)
8.6.2.4.2.3 Forecast Trend (2023-2028)
8.6.2.4.3 Others
8.7 Global Meningococcal Vaccines Market by Region
8.7.1 North America
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2017-2021)
8.7.1.3 Forecast Trend (2022-2027)
8.7.2 Europe
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2017-2021)
8.7.2.3 Forecast Trend (2022-2027)
8.7.3 Asia Pacific
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2017-2021)
8.7.3.3 Forecast Trend (2022-2027)
8.7.4 Latin America
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2017-2021)
8.7.4.3 Forecast Trend (2022-2027)
8.7.5 Middle East and Africa
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2017-2021)
8.7.5.3 Forecast Trend (2022-2027)
9 North America Meningococcal Vaccines Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2017-2021)
9.1.3 Forecast Trend (2022-2027)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2017-2021)
9.2.3 Forecast Trend (2022-2027)
10 Europe Meningococcal Vaccines Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2017-2021)
10.1.3 Forecast Trend (2022-2027)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2017-2021)
10.2.3 Forecast Trend (2022-2027)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2017-2021)
10.3.3 Forecast Trend (2022-2027)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2017-2021)
10.4.3 Forecast Trend (2022-2027)
10.5 Others
11 Asia Pacific Meningococcal Vaccines Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2017-2021)
11.1.3 Forecast Trend (2022-2027)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2017-2021)
11.2.3 Forecast Trend (2022-2027)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2017-2021)
11.3.3 Forecast Trend (2022-2027)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2017-2021)
11.4.3 Forecast Trend (2022-2027)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2017-2021)
11.5.3 Forecast Trend (2022-2027)
11.6 Others
12 Latin America Meningococcal Vaccines Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2017-2021)
12.1.3 Forecast Trend (2022-2027)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2017-2021)
12.2.3 Forecast Trend (2022-2027)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2017-2021)
12.3.3 Forecast Trend (2022-2027)
12.4 Others
13 Middle East and Africa Meningococcal Vaccines Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2017-2021)
13.1.3 Forecast Trend (2022-2027)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2017-2021)
13.2.3 Forecast Trend (2022-2027)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2017-2021)
13.3.3 Forecast Trend (2022-2027)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2017-2021)
13.4.3 Forecast Trend (2022-2027)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Pfizer Inc.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Sanofi SA
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 GlaxoSmithKline plc
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Incepta Vaccine Ltd.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Meningococcal Vaccines Market: Key Industry Highlights, 2018 and 2028
2. Global Meningococcal Vaccines Historical Market: Breakup by Type (Million Doses), 2018-2022
3. Global Meningococcal Vaccines Market Forecast: Breakup by Type (Million Doses), 2023-2028
4. Global Meningococcal Vaccines Historical Market: Breakup by Age Group (Million Doses), 2018-2022
5. Global Meningococcal Vaccines Market Forecast: Breakup by Age Group (Million Doses), 2023-2028
6. Global Meningococcal Vaccines Historical Market: Breakup by Distribution Channel (Million Doses), 2018-2022
7. Global Meningococcal Vaccines Market Forecast: Breakup by Distribution Channel (Million Doses), 2023-2028
8. Global Meningococcal Vaccines Historical Market: Breakup by Region (Million Doses), 2018-2022
9. Global Meningococcal Vaccines Market Forecast: Breakup by Region (Million Doses), 2023-2028
10. North America Meningococcal Vaccines Historical Market: Breakup by Country (Million Doses), 2018-2022
11. North America Meningococcal Vaccines Market Forecast: Breakup by Country (Million Doses), 2023-2028
12. Europe Meningococcal Vaccines Historical Market: Breakup by Country (Million Doses), 2018-2022
13. Europe Meningococcal Vaccines Market Forecast: Breakup by Country (Million Doses), 2023-2028
14. Asia Pacific Meningococcal Vaccines Historical Market: Breakup by Country (Million Doses), 2018-2022
15. Asia Pacific Meningococcal Vaccines Market Forecast: Breakup by Country (Million Doses), 2023-2028
16. Latin America Meningococcal Vaccines Historical Market: Breakup by Country (Million Doses), 2018-2022
17. Latin America Meningococcal Vaccines Market Forecast: Breakup by Country (Million Doses), 2023-2028
18. Middle East and Africa Meningococcal Vaccines Historical Market: Breakup by Country (Million Doses), 2018-2022
19. Middle East and Africa Meningococcal Vaccines Market Forecast: Breakup by Country (Million Doses), 2023-2028
20. Global Meningococcal Vaccines Market Structure
Key Questions Answered in the Report
In 2020, the global meningococcal vaccines market attained 172 million doses.
The major drivers of the industry, such as rising disposable incomes, increasing population, rising prevalence of the disease, and increasing demand for effective meningococcal vaccines, are expected to aid the market growth.
The key market trend guiding the growth of the industry includes the rise in the initiatives undertaken by the government.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading types of meningococcal vaccines in the market are polysaccharide vaccine (MPSV4), conjugate vaccine (MCV4), and serogroup B vaccine (MenB-FHpb/MenB-4C).
The major age groups considered in the market report are infants, children, and adults, among others.
The significant distribution channels in the industry are institutional sales and retail sales.
The major players in the industry are Pfizer Inc., Sanofi SA, GlaxoSmithKline plc, and Incepta Vaccine Ltd., among others.
Analyst Review
The global meningococcal vaccines market attained 172 million doses in 2020, driven by rising prevalence of urinary incontinence among the growing geriatric population. Aided by the technological advancements, the market is expected to witness a healthy growth in the forecast period of 2023-2028.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on type, the market is segmented into polysaccharide vaccine (MPSV4), conjugate vaccine (MCV4), and serogroup B vaccine (MenB-FHpb/MenB-4C). By age group, the industry is divided into infants, children, and adults, among others. On the basis of distribution channel, the market is segmented into institutional sales and retail sales. The major regional markets for meningococcal vaccines are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Pfizer Inc., Sanofi SA, GlaxoSmithKline plc, and Incepta Vaccine Ltd., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER